¤T¥Í»sÃÄ¥¸¸ê2.9»õ¬ü¤¸ ¦¬ÁÊTherapure¶}µo»s³y³¡ªù
¡i©ú³ø±M°T¡j¤¤°ê¤T¥Í»sÃÄ(3SBio Inc.)¦P·N¡M¥¸¸ê2.9»õ¬ü¤¸¡M¦¬ÁÊ¥[®³¤jTherapure Biopharma Inc.ªº¦X¬ù¶}µo¤Î»s³y³¡ªù¡C³o¬O¤¤°ê¥Íª«¬ì§Þ¤½¥q¦V¥_¬ü¥«³õ±À¶iªº¤@Ӱʧ@¡C
¸Ó¥æ©ö³q¹L¤T¥Í»sÃÄ»P¤¤«H²£·~§ë¸ê°òª÷ºÞ²z¤½¥q(Citic Private Equity Investment)³]¥ßªº¦XÀ礽¥q§¹¦¨¡C¤¤°ê»sÃÄ°Ó»P¥Íª«»sÃÄ¥ø·~¡M¥¿¦b±À¶i¼W¥[¦b¥þ²y¥«³õªº§ó¤j¥÷ÃB¡C
¤T¥Í»sÃÄ¥D®u°úÄv©ó©P¤éªºÁn©ú¤¤»¡¡G¡u¤T¥Í»sÃĪº¥þ²yÂX®iµ¦²¤¥Ø«e¥[³t¡C§Ú̧Ʊæ¡M¥[³t¶}µo»P°Ó·~¤Æ³Ð·s²£«~¡M´Â¦V¥O¥þ²y±wªÌ¨ü¯qªº²×·¥¥Ø¼Ð¡C¡v
Therapure¦b¥¦ªºÁn©ú¤¤»¡¡M¤T¥Í»sÃĬO¤@¶¡¤¤°ê¥Íª«»sÃĤj¤½¥q¡M·~°È«ÂI¦b¸~½F¬ì¡B¦Û§Ú§K¬Ì»PµÇŦ¯e¯fÃĪ«ªvÀø¡C¸Ó¤½¥qÁÙÀò±oTherapureªº¤@¨Ç¦å¼ß²£«~¤Î¬ì§Þ±M§Q¡M¥Î©ó¤¤°ê¥«³õ¡C
¸Ó¤¤°ê¤½¥q»P¥¦ªº¨p¶Ò°òª÷§ë¸ê¤½¥q¥ë¦ñ¡MÁÙ±N§ë¸ê¥t¥~2,000¸U¦Ü2,500¸U¥[¤¸(1,610¸U¦Ü2,020¸U¬ü¤¸)¡M¥Î©óTherapureªº¦å¼ß³J¥Õ»PªvÀø·~°È¡M¥Î©ó«Ø³y¤@®y·s³]¬I¡C
¸Ó¦X¬ù¶}µo»P»s³y³¡ªùTherapure Biomanufacturing¡M±NÄ~Äò¦bTherapure«~µP¤§¤UÀç¹B¡M¨Ã¥ÑTherapureªº²{¥ô¦æ¬FÁ`µô®æªL(Nick Green)¡M¥H¤Î¦b¦w¬Ù±K¦è¨F¥[¥«»s³y³]¬Iªº²{¥ô°ª¼h¹Î¶¤»â¾É¡C
Therapureªº±±ªÑ¤½¥q¬°¡M¥[®³¤j¨p¶Ò°òª÷§ë¸ê¤½¥qCatalyst Capital Group Inc.¡C¦Ó³o¶µ¥æ©ö¥Ñ´I°êÃÒ¨é(Wells Fargo Securities LLC)¡M§@¬°¥¦ªº¿W®a°]°ÈÅU°Ý¡C
Catalys±N«O«ù¹ïTherapure¦å¼ß³J¥Õ»PªvÀø²£«~·~°È¤À³¡ªº©Ò¦³Åv¡M±N¨ä§@¬°¤@Ó¿W¥ß¹êÅé¡C